Author:
Angus J. A.,Lew M. J.,Schwartz J.,Ross-Smith M.
Reference8 articles.
1. Manning M, and W.H. Sawyer. Discovery, development, and some uses of vasopressin and oxytocin antagonists. J. Lab. Clin. Med. 114: 617–632, 1989.
2. Angus J.A., A. Broughton and M.J. Mulvany. Role of alpha—adrenoceptors in constrictor responses of rat, guinea pig and rabbit small arteries to neural activation. J. Physiol. (Lond) 403: 495–510, 1988.
3. Lammek B., P. Rekowski, G. Kupryszewski, P. Melin, and U. Ragnarsson. Synthesis of arginine-vasopressins, modified in positions 1 and 2 as antagonists of the vasopressor response to the parent hormone. J. Med. Chem. 31: 603–606, 1988.
4. Kruszynski M., B. Lammek, and M. Manning [1-(ßmercapto-13,131-cyclopentamethylenepropionic acid), 2 (0-methyl) tyrosine] arginine-vasopressin and [1-(3mercapto-131 ß-cyclopentamethylenepropionic acid)] arginine-vasopressin, two highly potent antagonists of the vasopressor response to arginine-vasopressin. J. Med. Chem. 23: 364–368, 1980.
5. Arunlakshana O., and H. O. Schild. Some quantitative uses of drug antagonists. Brit. J. Pharmacol. 14: 48–58, 1959
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献